Electronic microscopy showed fragmented and partial (n ¼ 2) or complete (n ¼ 2) loss of elastic fibers. Treatment with plasma celledirected systemic chemotherapy (n ¼ 7) had no effect on CL outcome, except 1 partial subjective improvement of skin laxity with a regimen of bortezomib, cyclophosphamide, and dexamethasone. Immunomodulating intravenous immunoglobulin (n ¼ 2) had no effect on CL. Reconstructive surgical treatment (n ¼ 6) resulted in only short-term and temporary improvement. A review of the 42 previously reported cases was performed and is summarized in Table I . Our findings emphasize that acquired CL associated with MG is a chronic and unpredictable disease whose prognosis is mainly related to systemic implications, especially pulmonary, along with the course of the plasma cell disorder. The exact pathogenesis of CL associated with MG remains unclear, with no evidence of a correlation between the plasma cell disorder subtype and CL features or outcome. One hypothesis is that immunoglobulin deposition on elastic fibers triggers a cell-mediated immune response leading to their destruction by phagocytosis, as evidenced by direct immunofluorescence data revealing the deposition of immunoglobulin heavy chain or light chain on elastic fibers. [2] [3] [4] CL associated with HCDD had specific features, including kidney involvement, constant co-deposits of heavy chain and C3 in the skin, and serum hypocomplementemia, that could explain elastic fiber destruction. There is no evidence to support a specific definitive treatment to improve cutaneous and extracutaneous manifestations of CL, particularly emphysema. To conclude, the pathogenic role of a small immunoglobulin-producing clone in CL could be included in the spectrum of MG with cutaneous significance. Cytokine levels in persistent skin lesions of adult-onset Still disease
To the Editor: Adult-onset Still disease (AOSD) is an inflammatory disease characterized by fever, polyarthritis, and skin inflammation, with increased serum levels of interferon-(IFN-), interleukin 1 (IL-1), IL-18, IL-6, tumor necrosis factor-, IL-8, IL-2 receptor, C-X-C motif chemokine 10, and C-X-C motif chemokine 13 (CXCL13). 1 The cutaneous manifestations of AOSD include the classic evanescent skin eruption (ESE) and atypical persistent skin eruptions (APSEs), the latter possibly being related to more severe AOSD forms. 2 The aim of this study was to analyze the expression of key cytokines that are possibly involved in the skin inflammation of AOSD. A total of 13 patients with AOSD (according to the Yamaguchi and/or Fautrel criteria) with skin lesions (7 ESEs and 6 APSEs) and 9 healthy donors were included. Hematoxylin-eosinestained slides from all the patients were blindly examined by 2 pathologists (M.B. and M.D.V.P.). Total RNA was extracted from five 20-m-thick paraffin tissue sections. Quantitative polymerase chain reaction was performed with Applied Biosystems Power Sybr Green PCR Master Mix (Invitrogen, Carlsbad, CA).
APSEs manifested as linear urticaria (n ¼ 4), pigmented papules and plaques (n ¼ 1), and a dermatomyositis-like eruption (n ¼ 1). APSE histology showed a more abundant neutrophilic infiltrate and more frequent epidermal alterations.
Comparison between the skin of AOSD patients and that of healthy donors showed a significantly higher expression of IL-1 (P ¼ .04) and increased levels of expression of interferon-(IFN-) (P ¼ .06), IFN-(P ¼ .1), IL-6 (P ¼ .1), IL-8 (P ¼ .06), CD68 (P ¼ .1), and MCP-1 (P ¼ .1) in the skin of patients with AOSD (Fig 1) . Unexpectedly, level of expression of IL-18 was significantly lower (P ¼ .01) in the skin of patients with AOSD than in skin from healthy donors. The skin of patients with APSEs showed significantly higher levels of expression of IFN-(P ¼ .04), IFN-(P ¼ .04), IFN-receptor (P ¼ .003), and CXCL13 (P ¼ .02) and increased levels of expression of IL-6 (P ¼ .09), IL-8 (P ¼ .06), and CD68 (P ¼ .05) than the skin of patients with ESEs (Fig 2) . Expression of IFN-was particularly high in the dermatomyositis-like skin eruption (78 times more expressed in dermatomyositis-like skin eruption than in healthy donor skin vs 15 times more expressed in all 6 APSEs than in healthy donor skin).
In this work, IL-1 and IL-6 were up-regulated in the skin of patients with AOSD, confirming the interest in targeting these cytokines for treatment of Quantitative expression of RNA transcripts in skin of a patient with AOSD was normalized to that in skin from a healthy donor. IFN-, Interferon-; IFN-, interferon gamma; IL, interleukin; MCP1, monocyte chemoattractant protein 1.
